Effect of a (S)-(+)-decursin Derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic Acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester on Apoptosis of Eosinophils and Neutrophils in Normal and Asthmatic Subjects

  • Kim, In-Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University and Eulji University Medical Sciences Research Center) ;
  • Yang, Eun-Ju (Department of Clinical Laboratory Science, College of Health and Therapy, Daegu Hanny University) ;
  • Lee, Ji-Sook (Department of Clinical Laboratory Science, Wonkwang Health Science University)
  • Received : 2012.08.10
  • Accepted : 2012.08.30
  • Published : 2012.09.30

Abstract

(S)-(+)-3(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo3,4-dihydro-2H,8H-pyrano[3,2-g]Chromen-3-yl-ester (Compound 6, C6) is synthesized from (S)-(+)-decursin and attenuates the pathophysiologic progression of asthma in a ovalbumin-induced asthmatic mouse model. In the present study, we examined the effect of C6 on spontaneous apoptosis of eosinophils and neutrophils of normal and asthmatic subjects. C6 increased the apoptosis of asthmatic eosinophils in a dose-dependent manner, but it inhibited neutrophil apoptosis. C6 has no effect on apoptosis of normal eosinophils and neutrophils. LY294002, an inhibitor of PI3K, rottlerin, an inhibitor of $PKC{\delta}$, Ro-31-8425, an inhibitor of classical PKC inhibitor, PD98059, an inhibitor of MEK, and BAY 11-7085, an inhibitor of NF-${\kappa}B$, blocked the inhibitory effect on apoptosis of asthmatic neutrophils due to C6. These results indicate that C6 may be valuable as a therapeutic agent for the treatment of asthma.

Keywords

References

  1. Braman SS. The global burden of asthma. Chest 2006. 130: 4S-12S. https://doi.org/10.1378/chest.130.1_suppl.4S
  2. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol. 2003. 111: S799-S804. https://doi.org/10.1067/mai.2003.158
  3. Choi E, Yang EJ, Kim DH, Lee JS, Kim IS. CCR expression of bronchoalveolar lavage fluid (BALF) neutrophils and chemotactic activity of BALF. J Exp Biomed Sci. 2011. 17: 89-93.
  4. de Benedictis FM, Bush A. Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med. 2012. 185: 12-23. https://doi.org/10.1164/rccm.201107-1174CI
  5. Druilhe A, Letuve S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis. 2003. 8: 481-495. https://doi.org/10.1023/A:1025590308147
  6. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008. 38: 872-897. https://doi.org/10.1111/j.1365-2222.2008.02971.x
  7. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999. 160: 1532-1539. https://doi.org/10.1164/ajrccm.160.5.9806170
  8. Jiang C, Lee HJ, Li GX, Guo J, Malewicz B, Zhao Y, Lee EO, Lee HJ, Lee JH, Kim MS, Kim SH, Lu J. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Cancer Res. 2006. 66: 453-463. https://doi.org/10.1158/0008-5472.CAN-05-1865
  9. Lee S, Shin DS, Kim JS, Oh KB, Kang SS. Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res. 2003. 26: 449-452 https://doi.org/10.1007/BF02976860
  10. Scheel-Toellner D, Wang KQ, Webb PR, Wong SH, Craddock R, Assi LK, Salmon M, Lord JM. Early events in spontaneous neutrophil apoptosis. Biochem Soc Trans. 2004. 32: 461-464. https://doi.org/10.1042/BST0320461
  11. Yang EJ, Lee JS, Yun CY, Kim IS. The pro-apoptotic effect of hydroquinone in human neutrophils and eosinophils. Toxicol In Vitro. 2011. 25: 131-137. https://doi.org/10.1016/j.tiv.2010.10.004
  12. Yang EJ, Song GY, Lee JS, Yun CY, Kim IS. A novel (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester, inhibits ovalbumin-induced lung inflammation in a mouse model of asthma. Biol Pharm Bull. 2009. 32: 444-449. https://doi.org/10.1248/bpb.32.444